A combination of gemcitabine and the Shh inhibitor IPI-926 has been used in a pancreatic cancer mouse model, and the results showed increased gemcitabine concentrations in the tumor and stabilized the disease (Olive et al., 2009). The gene discussed is SHH; the disease is familial pancreatic carcinoma.